Abivax (ABVX) Non-Current Debt (2022 - 2025)

Abivax's Non-Current Debt history runs 4 years deep, the most recent figure standing at $35.8 million for Q4 2025.

• In Q4 2025, Non-Current Debt changed N/A year-over-year to $35.8 million; the TTM figure through Dec 2025 stood at $35.8 million (changed N/A YoY), while the FY2025 annual figure was $35.8 million, changed N/A from the prior year.
• Non-Current Debt was $35.8 million for Q4 2025 at Abivax, up from $4.9 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $42.7 million in Q4 2023 to a low of $2.7 million in Q2 2024.
• Historically, Non-Current Debt has averaged $20.3 million across 4 years, with a median of $25.1 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Non-Current Debt surged 1183.38% in 2023, then surged 925.84% in 2025.
• A 4-year view of Non-Current Debt shows it stood at $3.3 million in 2022, then soared by 1183.38% to $42.7 million in 2023, then sank by 93.75% to $2.7 million in 2024, then jumped by 1242.01% to $35.8 million in 2025.
• The last three Non-Current Debt figures came in at $35.8 million (Q4 2025), $4.9 million (Q3 2025), and $27.4 million (Q2 2025), per Business Quant data.